Statistics from Altmetric.com
Mycophenolate mofetil (MMF) is a systemic immunosuppressive agent widely used to prevent solid organ transplant rejection. It has also been used to treat a variety of systemic autoimmune conditions.1–3 Several papers have described its use to treat predominantly posterior segment ocular inflammatory conditions.4–7 We have reviewed our experience using MMF to treat anterior segment conditions.
From our immunosuppression database and electronic patient records we identified patients in the hospital who had taken MMF to treat severe inflammatory external eye conditions.
Patient response to MMF treatment was classified as success—no inflammation after induction MMF treatment either as monotherapy …